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1 Introduction 17 
Obesity is an increasing global public health challenge DQGWRGD\¶VPDLQDSSURDFKin prevention and 18 
treatment of obesity is promotion of a healthy diet and physical exercise1. Many interventions are 19 
known to result in weight loss; however, enhanced appetite, i.e. increased feelings of hunger and 20 
lack of satiety, have been found to reduce adherence to the required reductions in energy intake and 21 
consequently to limit weight loss and to make weight loss maintenance a real challenge2±4.  22 
Appetite, and hence the ability to control energy intake, is to a high degree influenced by interaction 23 
between tonic and episodic signals aiming to regulate energy homeostasis5±7. These signals 24 
ultimately influence centers in the brain involved in eating behavior, especially hypothalamus, 25 
hindbrain and brainstem8±11. Centers in the hypothalamus also play a role in the psychological 26 
stimuli of hedonic appetite; i.e. the desire and cravings for food especially associated with highly 27 
palatable foods, which is mediated by cognitive reward10,12. Although anatomically separated, these 28 
homeostatic and hedonic systems are functionally highly integrated and both are affected by a 29 
plethora of signals from peripheral organs influencing our motivation to eat13. Feelings of hunger 30 
and satiety play major roles in controlling how much energy is consumed, and accordingly, levels 31 
of perceived hunger and satiety may predict the individual¶Vability to manage their body weight14. 32 
It has been shown that the orexigenic hormone (ghrelin) increases, whereas anorexigenic hormones 33 
(e.g. glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and leptin) decrease following weight 34 
loss15±17. Thereby, it seems reasonable to assume that these counteracting mechanisms, may at least 35 
partly, limit weight loss and be important for the failed weight loss maintenance typically seen even 36 
after very successful weight loss18. Furthermore, energy expenditure, both at rest as well as the costs 37 
of weight-bearing physical activities, is reduced after weight loss. Energy expenditure is reduced 38 
even after reaching energy balance, which adds to the challenge of achieving further weight loss 39 
and especially to maintain the weight loss by means of continuous attempts to restrict energy 40 
intake19,20.  41 
Thus, it seems reasonable to consider appetite as a promising target in the progression towards more 42 
effective means to be used for prevention and treatment of obesity. New and innovative food 43 
concepts, designed to have satiety enhancing and/or hunger reducing capacities, including within-44 
meals satiation and post-meal satiety, may be useful tools in the struggle for successful sustained 45 
body weight management, health improvement and decreased risk of chronic disease5,21,22.  46 
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Although administration of pharmaceuticals that reduce appetite (e.g. GLP-1 analogs23) result in 47 
weight loss24, pharmaceutical¶V effects on appetite have seldom been assessed in the same study as 48 
assessment of the effects on body weight management, making the link between appetite and body 49 
weight management less obvious. Nevertheless, it is not questioned that the effect on appetite is the 50 
main mechanism by which these drugs lead to weight loss. However, there is presently no 51 
consensus that consumption of foods with enhanced capacity to reduce appetite will have a 52 
beneficial effect on body weight management in the context of overweight and obesity. Hence, an 53 
authoritative body like the European food safety authority (EFSA) does not consider a reduction in 54 
DSSHWLWHWREHD³EHQHILFLDOSK\VLRORJLFDOHIIHFW´per se in the context of body weight management 55 
ZKHQHYDOXDWLQJKHDOWKFODLPVDSSOLFDWLRQ,QWKHLU³*XLGDQFHRQWKHVFLHQWLILFUHTXLUHPHQWVIRU56 
KHDOWKFODLPVUHODWHGWRDSSHWLWHUDWLQJV´LWLVVWDWHGWKDW³HYLGHQFHIRUDVXVWDLQHGHIIHFWRQDSSHWLWH57 
ratings and RQERG\ZHLJKWZLWKFRQWLQXHVFRQVXPSWLRQRIWKHIRRGVKRXOGEHSURYLGHG´25.  58 
Currently, there is intense interest in foods characterized by their improved satiety enhancing and/or 59 
hunger reducing capacities based on the assumption that if included in the diet, these will assist the 60 
consumer in achieving energy restriction and thereby help to lose/maintain body weight. However, 61 
these hypotheses call for studies conducted without bias to reveal whether true inter-relationships 62 
between these variables are reliable and valid. The outcome of these examinations have both 63 
theoretical and practical value; they will disclose processes that operate in the expression of human 64 
appetite, and they will indicate whether specific foods exist that have the capacity to influence 65 
appetite and, in turn, modulate body weight. Clarification is required in an area, which is largely 66 
affected by opinions and hyperbole and where data can be reported ambiguously. 67 
The usefulness of reducing appetite in order to regulate body weight is highly debated26±28. The 68 
connection between single self-reported appetite evaluations, the following energy intake and if this 69 
subsequently has the ability to affect body weight regulation, has been questioned29,30. Nevertheless, 70 
it seems plausible to assume that robust effects on feelings of appetite are likely to influence energy 71 
intake, and if an intervention is able to reduce feelings of appetite sufficiently to reduce energy 72 
intake, ultimately body weight management must be improved.    73 
Therefore, this review aims to summarize and discuss the existing evidence from clinical trials 74 
investigating whether interventions that enhance satiety and/or reduce hunger lead to beneficial 75 
effects on body weight management in the context of overweight and obesity.  76 
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2 Method 77 
Using the PRISMA guidelines, a comprehensive review protocol identifying objectives (including 78 
PICO (patient/population; intervention; comparison; outcome) and methods was prepared in 79 
collaboration between the authors in advance of the systematic literature search31. The search 80 
strategy and requirements for the studies to be eligible for inclusion is described below.   81 
2.1 Search strategy 82 
After screening of MeSH term index list as well as testing numerous different combinations of 83 
search terms in order to conduct a search providing the most hits, the following search terms were 84 
selected as the final search syntax: µ³appetite´ OR ³satiety´OR ³satiation´ OR ³satiety 85 
response´ OR ³hunger´ OR ³hunger response´ OR ³hungry´$1'´body weight changes´ OR 86 
³body weight maintenance´ OR ³weight loss´ OR ³weight gain´¶6HDUFKRQWLWOHDEVWUDFWZHUH87 
combined with search on medical subject headings (MeSH terms) restricted to clinical trials in 88 
humans reported in English. The systematic automated literature search was done in PubMed and 89 
identified studies potentially eligible for inclusion and available on PubMed up to February 22, 90 
2019 (Figure 1).  91 
2.2 Inclusion and exclusion criteria 92 
In order to provide an overview of the current body of evidence on the assumed link between 93 
reduced appetite and beneficial effects on body weight management; the following conditions were 94 
required for studies to be included in this review. The study populations eligible comprised adults 95 
and adolescents with overweight or obesity but otherwise healthy. Long-term interventions (8 96 
weeks intervention was defined as long-term) assessing difference in acute and/or sustained appetite 97 
along with potential changes in body weight over the study period were required. Significant 98 
differences in appetite between the intervention and control were required in order to be able to 99 
examine whether differences in the effect on appetite could be linked to body weight management. 100 
Differences in the effect on appetite could be assessed within or between subjects as long as an 101 
effect of the intervention compared to a relevant control was demonstrated. Potential difference in 102 
the effect on appetite was assessed either by acute effects measured at baseline after a single 103 
exposure or by sustained effects after repeated exposures. To demonstrate sustained effects on 104 
appetite, appetite measurements needed to be performed after a long-term intervention with 105 
repeated exposures of the intervention products, where a sustained difference in appetite between 106 
intervention and control should be demonstrated. Body weight management assessed as body 107 
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weight maintenance, weight loss and/or weight gain/regain in kg monitored in laboratory settings 108 
was required.  109 
2.3 Assessments of appetite 110 
In appetite research, three methodologies are commonly used: Ad libitum energy intake assessed 111 
after exposure to a test food/product or meal; self-reported appetite evaluations, typically using 112 
visual analogue scales (VAS); biological markers of appetite assessed through blood samples 113 
obtained in response to a meal32. At least one of the two first mentioned methodologies had to be 114 
applied in the studies in order to be eligible for this review. Additionally, appetite was required to 115 
be monitored in laboratory settings in order for the results to be comparable and to minimize bias 116 
from unstandardized measurements33,34. The most common type of VAS for assessments of self-117 
reported appetite evaluations comprises a 100 mm horizontal line with words anchored at each end 118 
expressing the most positive and most negative feeling of a given appetite sensation. Appetite 119 
VHQVDWLRQVFDQEHH[SUHVVHGE\GLIIHUHQWZRUGLQJVEXWPRVWRIWHQ³KXQJHU´³GHVLUHWRHDW´DQG120 
³SURVSHFWLYHFRQVXPSWLRQ´DUHXVHGDVPDUNHUVIDYRULQJPRWLYDWLRQWRHDWZKHUHDV³VDWLHW\´DQG121 
³IXOOQHVV´DUHXVHGDVPDUNHUVRIDUHGXFHGPRWLYDWLRQWRHDW32. Other validated scales used to assess 122 
self-reported appetite evaluations were also accepted and found suitable for comparisons, as long as 123 
they were used in laboratory settings. It can be expected that feelings of appetite translate into 124 
behavior and thereby is reflected in energy intake. Nevertheless, some reports argue that appetite 125 
ratings may not necessarily be related to energy intake29,30. In this review, we chose to examine 126 
appetite based on both methodologies as self-reported appetite evaluations were found to be 127 
relevant though not necessarily translated into energy intake in a laboratory setting. In real life, we 128 
H[SHFWWKDWDQLQGLYLGXDO¶V perception of appetite has a great impact on what is actually consumed. 129 
In order for the effect on the perception of appetite to have an impact on body weight, a lower 130 
energy intake is necessary. Thereby, both of these methodologies for assessing appetite were found 131 
relevant for this review; however, results on appetite from energy intake were separated from self-132 
reported appetite evaluations and not directly compared.   133 
2.4 Type of interventions 134 
Interventions including use of foods/meals, food supplement and pharmaceuticals were included 135 
DQGDOOLQWHUYHQWLRQVDUHUHIHUUHGWRDV³IRRGV´ in this review. In order to identify studies 136 
investigating interventions solely affecting appetite and not energy metabolism etc., studies 137 
including pharmaceuticals were evaluated carefully in order to identify whether a potential effect of 138 
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the drug on energy metabolism could be ruled out based on its mode of actions. For the same 139 
reason, interventions including different levels of physical activity were evaluated as non-eligible.  140 
2.5 Study selection 141 
After each search, two independent authors identified papers eligible for full-text screening on the 142 
basis of titles and abstracts. Full-text screening was then performed by three independent authors. 143 
All three authors discussed data extraction, interpretation of results and risk of bias, which was 144 
ultimately recorded by one author. If need for further clarifications, consensus on interpretation of 145 
results was discussed between all authors.  146 
2.6 Meta-analysis 147 
A random effects meta-analysis was performed on the differences in body weight change (kg) 148 
between subjects exposed to satiety enhancing and/or hunger reducing foods compared to controls 149 
in the respective studies. If mean difference in body weight change (95% confidence interval (CI)) 150 
(kg) was not directly reported in the studies, the effect sizes were calculated based on reported 151 
changes within each group. If no standard deviation, standard error of mean or 95% CI for the 152 
changes in body weight between groups or within each group was reported, the corresponding 153 
authors were asked to provide these data. If data was not available, the 95% CI was imputed based 154 
on the average SEM from the other studies35. The assessments of appetite were categorized 155 
according to whether appetite was assessed as energy intake from an ad libitum meal and self-156 
reported appetite evaluations, energy intake from an ad libitum meal alone or self-reported appetite 157 
evaluations alone. The meta-analysis was carried out using Stata/SE 15.1 (StataCorp).   158 
2.7 Risk of bias assessments 159 
The studies were rated based on whether they support that satiety enhancing and/or hunger reducing 160 
interventions are linked with beneficial effects on body weight management (+) or not (-). 161 
$GGLWLRQDOO\EDVHGRQWKH&RFKUDQHFROODERUDWLRQ¶VWRROIRUDVVHVVLQJULVNRIELDV35 and on known 162 
major sources of bias within appetite research, the following criteria were assessed: random 163 
sequence generation (selection bias); allocation concealment (selection bias); blinding of 164 
participants and personnel (performance bias); blinding of outcome assessment (detection bias); 165 
incomplete outcome data (attrition bias); selective reporting (evaluated for self-reported appetite 166 
evaluations) (reporting bias); power calculation; drop outs; other bias. Risk of bias was rated as 167 
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³/RZ´ RU³+LJK´DFFRUGLQJWRpredefined specifications (see Supplementary material Table 1) or 168 
³8QFOHDU´LIQRLQIRUPDWLRQ on a potential bias was reported.    169 
3 Results 170 
From the total of 517 unique papers identified, screening based on titles and abstracts resulted in a 171 
selection of 38 papers for full-text screening. A total of 12 papers met the predefined inclusion 172 
criteria and were accordingly found eligible for inclusion in this review. The reference lists of these 173 
12 eligible papers were subsequently screened and additional 12 potentially relevant papers were 174 
selected for full-text screening. However, these were subsequently excluded for further 175 
considerations (Figure 1). Of the final 12 papers included, 4 tested acute and 9 sustained effects on 176 
appetite (Table 1 and Table 2, respectively).    177 
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Table 1 Acute effects of appetite assessed after a single exposure on body weight management. 178 
Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95%CI) difference I 
vs. C after intervention) 
Appetite assessed after a single exposure  
(Mean difference I vs. C prior to intervention) R* 
Energy intake Self-reported appetite 
evaluations 
Chambers et al. 2015  
 
Supplement:    
I: Inulin-propionate ester 
C: Inulin-control 
49 (19/30), 
54.5±1.5,  
25-40 
DB P RCT,  
24 weeks,  
95% (no 
difference, 
P=0.864)  
,ļ 
(-1.0±3.0, P=0.062) 
 
&ļ 
(+0.4±2.9, P=0.559) 
 
'LIIHUHQFHļ 
(-1.4 (-3.07; 0.27), P=0.099) 
Ļ 
(-162 kcal, 
P<0.01) 
 
- 
Dennis et al. 2010 
 
Food: 
I: Hypocaloric diet + 500 
ml bottled water  
C: Hypocaloric diet alone 
48 (18/30), 
62.4±1.1, 
32.8±1.1 
NB P RCT,  
12 weeks,  
I: 90% 
(consumption of 
water 
controlled) 
I: Ļ  
(-7.4±0.6, P<0.001) 
 
C: Ļ  
(-5.2±0.6, P<0.001) 
 
Difference: Ļ  
(-2.3 (-3.61; -0.99), P<0.001)  
Ļ 
(-43 kcal, 
P=0.009) 
 
 
+ 
Jakubowicz et al. 2012 
 
Food; 
Isocaloric low 
carbohydrate diets but 
with different breakfasts:  
I: High carbohydrate and 
protein (high calorie 
breakfast) 
C: Low carbohydrate (low 
calorie breakfast) 
144 (58/86), 
47.1±6.8, 
32.3±1.9 
NB P RCT,  
16 weeks calorie 
restriction + 16 
week follow up, 
NR (food 
checklists used 
but data not 
reported)  
,Ļ" 
(-7.0±0.7, P=NR) 
 
&Ĺ" 
(+11.7±0.7, P=NR) 
 
'LIIHUHQFHĻ 
(-18.7 (-21.23; -16.17), 
P<0.0001) 
 6DWLHW\Ĺ 
(AUC240 min: +66%, P<0.0001) 
 
+XQJHUĻ 
(AUC240 min: -46%, P<0.0001) 
 + 
Wang et al. 2015 
 
Food; Isoenergic 
breakfasts:    
I: Egg 
C: Steamed bread 
156 (80/76), 
14.6±2.2, 
32.1+1.7 
NB P RCT,  
12 weeks, 
No difference 
(data not 
reported) 
I: Ļ (?) 
(-2.3, (calculated from %), 
P=NR) 
 
C: Ļ" 
(-0.1, (calculated from %), 
P=NR) 
 
Ļ 
(-116 kcal, 
P<0.001) 
  
6DWLHW\Ĺ 
(120 min:  
+8.4 mm, P<0.001;  
180 min:  
+10.3 mm, P<0.001)  
 
)XOOQHVVĹ 
(120 min:  
+ 
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Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95%CI) difference I 
vs. C after intervention) 
Appetite assessed after a single exposure  
(Mean difference I vs. C prior to intervention) R* 
Energy intake Self-reported appetite 
evaluations 
Difference: Ļ 
(-2.2, P<0.001) 
+14.7 mm, P<0.001;  
180 mi:  
+10.1 mm, P<0.001)  
 
Hunger: Ļ  
(120 min:  
-10.4 mm, P<0.001;  
180 min:  
-10.6 mm, P<0.001)  
  
Prospective FRQVXPSWLRQĻ 
(120 min:  
-9.8 mm, P<0.001;  
180 min:  
-9.7 mm, P<0.001) 
M=Male; F=Female; SEM=Standard error of mean; I=Intervention; C=Control; CI=Confidence interval; DB=Double-blinded; SB=Single-blinded; NB=Non-blinded; 179 
P=Parallel; RCT=Randomized controlled trial; NR=not reported; AUC=Area under the curve; Ĺ ,QFUHDVHKLJKHUĻ=Decrease/lower; ļ=unchanged/no difference; 180 
(?)=Significance of difference is unknown. 181 
*R=Rating of the study. The rating represents whether the study supports that satiety enhancing and/or hunger reducing interventions are linked with beneficial effects 182 
on body weight management (+) or not (-). 183 
The grey areas indicate that the parameters were not assessed.  184 
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3.1 Are acute effects on appetite after a single exposure to satiety enhancing and/or 185 
hunger reducing foods linked to beneficial effects on body weight management? 186 
3.1.1 Support from studies assessing the acute effects on appetite based on energy intake from an 187 
ad libitum meal after a single exposure of satiety enhancing and/or hunger reducing foods 188 
The studies from the groups of Dennis and Wang found the lower energy intake from the ad libitum 189 
meals to be linked to superior weight losses in the intervention groups compared to the control 190 
groups (Table 1)36,37. Wang et al. found individual changes in ad libitum energy intake to be 191 
strongly associated with weight loss, explaining 58% of the variation (P<0.001)37.  192 
Body weight maintenance also tended to be different between the groups in the study by Chambers 193 
et al.. The intervention group tended to lose weight, whereas the body weight in the control group 194 
pointed towards weight gain. This tendency was, according to the authors, further supported by the 195 
fact that none of the participants in the intervention JURXSKDGVXEVWDQWLDOZHLJKWJDLQfrom 196 
baseline body weight) compared with 4 of 24 (17%) in the control group (P=0.033)38. Thus, there is 197 
some support for the reduced appetite found after a single exposure in the intervention group 198 
compared to the control group to be linked to beneficial changes in body weight during the 199 
following intervention period in this study (Table 1).  200 
3.1.2 Support from studies assessing the acute effects on appetite based on self-reported 201 
evaluations after a single exposure of satiety enhancing and/or hunger reducing foods 202 
The studies by Jakubowicz et al. and Wang et al. found lower reported motivation to eat in the 203 
intervention groups after consumption of the intervention foods compared to the control groups to 204 
be linked to superior weight loss regardless of the scales used37,39. The latter study thereby 205 
consistently found a reduced appetite in the intervention group both when assessed as ad libitum 206 
energy intake as well as based on self-reported appetite evaluations, resulting in compelling overall 207 
evidence from this study37. In the study by Jakubowicz et al., the reported reduced appetite in the 208 
intervention group compared to the control group was found after a single exposure of the 209 
intervention food prior to a 16 week intervention period with calorie restriction (1600 kcal for men 210 
and 1400 kcal for women). After that, the participants were instructed to continue to consume the 211 
intervention foods for an additional 16 weeks, but during this time, they were instructed to eat as 212 
motivated by appetite. Comparable weight loss was found in both groups after the 16 weeks of 213 
calorie restriction (intervention group: -13.5±2.3 kg; control group: -15.1±1.9 kg, P=0.11), but 214 
additional weight loss was found after the following 16 weeks in the intervention group, whereas 215 
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the control group regained weight, resulting in a substantial difference between the intervention and 216 
the control group39 (Table 1/Table 2).  217 
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Table 2 Sustained effects of appetite assessed after repeated exposures on body weight management. 218 
Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95% CI) difference I 
vs. C after intervention) 
Appetite assessed after repeated exposures  
(Mean difference I vs. C after intervention) R* 
Energy intake Self-reported appetite 
evaluations 
Blundell et al. 2017 
 
Pharmaceutical:  
I: Semaglutide (1.34 
mg/ml) dose-escalated to 
1.0 mg 
C: Placebo 
 
Both administered once 
weekly 
28 (18/9), 
42,  
33.8 
DB CO RCT,  
12 weeks + 5-7 
weeks wash-out, 
Pharmacokinetic
s profile 
assessed after 4, 
8 and 12 weeks 
supported 
compliance 
 
,Ļ" 
(-5.0, P=NR) 
 
&RQWUROĹ" 
(+1.0, P=NR) 
 
'LIIHUHQFHĻ" 
(-6.0, P=NR) 
(only assessed 
after 
intervention) 
'LIIHUHQFHĻ 
(Ad libitum 
lunch: -1255 
kJ, 
P<0.0001;  
Ad libitum 
total day time 
energy intake: 
-3036 kJ, 
P<0.0001) 
6DWLHW\Ĺ" 
(Fasting VAS rating:  
~ +5 (read on Figure 2C in 
original paper), P=NR) 
 
)XOOQHVVĹ" 
(Fasting VAS rating:  
~ +15 (read on Figure 2C in 
original paper), P=NR) 
 
+XQJHUĻ" 
(Fasting VAS rating:  
~ -20 (read on Figure 2C in 
original paper), P=NR) 
 
Prospective FRQVXPSWLRQĻ (?) 
(Fasting VAS rating:  
~ -15 (read on Figure 2C in 
original paper), P=NR) 
+ 
Diepvens et al. 2007 
 
Supplement:  
I: Olibra (a novel fat 
emulsion; 5 gram provided 
in 250 gram yoghurt per 
day)  
C: Placebo (5 gram milk 
provided in 250 gram 
yoghurt per day)  
50 (0/50), 
40.8±9.5, 
28.7±2.0 
DB P RCT, 
6 weeks very 
low-calorie 
formula diet 
(500 kcal/day) + 
18 weeks 
intervention,  
NR (evaluated 
every week by 
personal 
interview with a 
dietician but 
data not 
reported) 
,ļ 
(+1.13±0.7, P>0.05) 
 
&RQWUROĹ 
(+2.95±0.6, P<0.001) 
 
'LIIHUHQFHĻ 
(-1.82 (-3.67; 0.00), P=0.05) 
 Hunger: Ļ 
(AUC240 min: -16.2 mm, 
P<0.05) 
+ 
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Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95% CI) difference I 
vs. C after intervention) 
Appetite assessed after repeated exposures  
(Mean difference I vs. C after intervention) R* 
Energy intake Self-reported appetite 
evaluations 
Jakubowicz et al. 2012 
 
Food; 
Isocaloric low 
carbohydrate diets but 
with different breakfasts:  
I: High carbohydrate and 
protein (high calorie 
breakfast) 
C: Low carbohydrate (low 
calorie breakfast) 
144 (58/86), 
47.1±6.8, 
32.3±1.9 
NB P RCT,  
16 weeks calorie 
restriction + 16 
weeks 
intervention, 
NR (food check 
lists used but 
data not 
reported)  
,Ļ" 
(-7.0±0.7, P=NR) 
 
&Ĺ" 
(+11.7±0.7, P=NR) 
 
'LIIHUHQFHĻ 
(-18.7 (-21.23; -16.17), 
P<0.0001) 
 Satiety: Ĺ 
(AUC240 min:+65% , P<0.0001) 
 
Hunger: Ļ 
(AUC240 min: -51%, P<0.0001) 
 + 
Kamphuis et al. 2003 
 
Supplement:  
I: Conjugated linoleic acid 
(CLA) (TonalintTM CLA 
75% TG - 9.11-
Octadecadienoic acid, 
10.12-Octadecadienoic 
acid) 
C: Oleic acid 
 
Capsules to be taken 
before breakfast, lunch and 
dinner every day. 
Two different doses were 
provided of I and C, 
respectively (1.8 and 3.6 
gram/day). Results 
presented with low and 
high dose combined  
54 (26/28), 
38.0±8.0, 
27.8±1.5 
DB P RCT,  
3 weeks very 
low-calorie 
formula diet 
(500 kcal/day) + 
13 weeks 
intervention, 
NR  
,ļ 
(+2.4±1.1, P>0.05)   
 
&ļ 
(+1.8±1.2, P>0.05)   
 
'LIIHUHQFHļ 
(+0.6 (-4.05; 5.25), P>0.05) 
,ļ 
(0.0) 
 
&ļ 
(0.0) 
 
'LIIHUHQFHļ 
(+23.8 kcal, 
P>0.05)  
Satiety: Ĺ 
(~ +10 mm (read in Figure 3 in 
original paper), P<0.05) 
 
Fullness: Ĺ 
(~ +10 mm (read in Figure 2 in 
original paper), P<0.05) 
 
Hunger: Ļ 
(~ -20 mm (read on Figure 4 in 
original paper), P<0.05) - 
Kudiganti et al. 2016 
 
Supplement: 
I: Meratrim (flower heads 
of 
60 (24/26), 
38.1±1.7, 
28.3±0.3 
DB P RCT,  
16 weeks, 
95% (no 
difference, data 
not reported) 
,Ļ" 
(-5.1±0.4, P=NR) 
 
&Ļ" 
(-1.1±0.5, P=NR) 
 
 Composite appetite score: Ļ 
(-183.8, P<0.001) 
+ 
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Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95% CI) difference I 
vs. C after intervention) 
Appetite assessed after repeated exposures  
(Mean difference I vs. C after intervention) R* 
Energy intake Self-reported appetite 
evaluations 
Sphaeranthus indicus (S. 
indicus) and the fruit rinds 
of Garcinia mangostana 
(G. mangostana), 3:1)  
C: Only excipients  
'LIIHUHQFHĻ 
(-4.0 (-3.18; -4.82), P<0.0001) 
Martin et al. 2011 
 
Pharmaceutical: 
I: Lorcaserin (10 mg twice 
daily)   
C: Placebo 
57 (18/39), 
48.7±12.7, 
35.6±4.8 
DB P RCT,  
8 weeks,  
NR 
,Ļ 
(-3.8±0.4, P<0.05) 
 
&Ļ 
(-2.2±0.5, P<0.05) 
 
'LIIHUHQFHĻ 
(-1.6 (-2.88; -0.32), P<0.01) 
,Ļ 
(-470 kcal, 
P<0.05) 
 
&Ļ 
(-205 kcal, 
P<0.05) 
 
Difference: Ļ 
(-264 kcal, 
P<0.05) 
Fullness:  
(NR) 
 
Hunger:   
(NR) 
 
Desire to eat:  
(NR) 
 
Prospective consumption: Ļ 
(-13 mm, P=0.004) 
+ 
Rigaud et al. 1990 
 
Supplement;  
Hypocaloric diet including 
fiber capsules (mixture of 
beet, barley, citrus 
(approximately 90% 
insoluble fiber)):  
I: 7 gram fiber 
C: 1 gram fiber 
 
52 (11/41), 
36.9±2.3, 
29.3±0.8 
DB P RCT,   
24 weeks, 
NR (counting of 
capsules every 
month but data 
not reported) 
,Ļ 
(-5.5±0.7, P=0.0001) 
 
&Ļ 
(-3.0±0.5, P<0.0001) 
 
'LIIHUHQFHĻ 
(-2.5 (-4.25; -0.75), P=0.005) 
 HungerĻ" 
(~ -23 mm, P=NR) 
+ 
Rondanelli et al. 2009 
 
Supplement:  
I: N-oleyl-
phosphatidylethanolamine/
epigallocatechin- 
3-gallate 
(PhosphoLEANTM) 
complex 
C: Placebo 
138 (32/106), 
39.5±11,  
25-35 
DB P RCT,  
8 weeks,  
I: 94%; C: 73%, 
P<0.001 
,Ļ" 
(-3.28 (-4.1; -2.5), P=NR) 
 
&Ļ" 
(-2.67 (-3.5; -1.8), P=NR) 
 
'LIIHUHQFHļ 
(-0.61 (-1.76; 0.54), P=0.296) 
 Fullness: Ĺ 
(+0.79 mm, P=0.041) 
- 
15 
 
Reference 
 
Intervention 
Population 
(n (M/F), 
age(years), 
BMI(kg/m2)) 
Design 
(type, length, 
compliance) 
Body weight (kg) 
(Mean±SEM change in I and C 
+ Mean (95% CI) difference I 
vs. C after intervention) 
Appetite assessed after repeated exposures  
(Mean difference I vs. C after intervention) R* 
Energy intake Self-reported appetite 
evaluations 
 
One capsule before lunch 
and one before dinner 
every day 
Sofer et al. 2011  
 
Food;  
Standard low calorie diet 
(20% protein, 30±35% fat, 
45±50% carbohydrates 
providing 1.300±1.500 
kcal/day): 
I: Carbohydrates provided 
mostly at dinner 
C: Carbohydrates provided 
throughout the day 
66 (32/34), 
42.8±7.1, 
33.2±3.7 
NB P RCT,  
24 weeks,  
NR 
(comprehensive 
inquiry and 
estimate 
adherence 
to dietary 
regimen and 
caloric intake 
was evaluated 
by a dietician 
and 
incompliance 
resulted in 
exclusion) 
,Ļ 
(-11.6±0.8, P<0.0001) 
 
&Ļ 
(-9.06±0.8, P<0.0001) 
 
'LIIHUHQFHĻ 
(-2.54 (-2.94; -2.14), P=0.024) 
 SatietyĹ 
(HSSc: +20%, P=0.03) 
+ 
M=Male; F=Female; SEM=Standard error of mean; I=Intervention; C=Control; CI=Confidence interval; DB=Double-blinded; SB=Single-blinded; NB=Non-blinded; 219 
CO=Cross-over; P=Parallel; RCT=Randomized controlled trial; NR=not reported; VAS=Visual analogue scale; AUC=Area under the curve; HSSc=Hunger-satiety 220 
score; Ĺ ,QFUHDVHKLJKHUĻ=Decrease/lower; ļ=unchanged/no difference; (?)=Significance of difference is unknown. 221 
*R=Rating of the study. The rating represents whether the study supports that satiety enhancing and/or hunger reducing interventions are linked with beneficial effects 222 
on body weight management (+) or not (-). 223 
The grey areas indicate that the parameters were not assessed.224 
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3.2 Are sustained effects on appetite after repeated exposures to satiety enhancing 225 
and/or hunger reducing foods linked to beneficial effects on body weight 226 
management? 227 
3.2.1 Support from studies assessing the sustained effects on appetite based on energy intake from 228 
an ad libitum meal after repeated exposures of satiety enhancing and/or hunger reducing 229 
foods 230 
In the studies from the groups of Blundell and Martin, reduced energy intake from an ad libitum 231 
meal in the intervention groups was found to result in pronounced weight loss compared to the 232 
control groups (Table 2)40,41. This was further supported by the latter group showing a positive 233 
association between individual reduction in energy intake and reduction in body weight. The 234 
individual reductions in ad libitum energy intake in this study explained 23% of the variation in 235 
weight reduction (P<0.001)41.      236 
3.2.2 Support from studies assessing the sustained effects on appetite based on self-reported 237 
evaluations after repeated exposures of satiety enhancing and/or hunger reducing foods 238 
The studies from the groups of Blundell, Diepvens, Jakubowicz, Kudiganti, Martin, Rigaud, and 239 
Sofer all found reduced appetite in the intervention groups compared to the control groups after 240 
repeated exposures to be linked to superior weight losses (Table 2)39±45. Blundell et al. and 241 
Jakubowicz et al. found reduced appetite in the intervention groups compared to the control groups 242 
regardless of the scales used39,40. Kudiganti et al. reported the self-reported appetite evaluations in 243 
the form of a composite appetite score while Sofer et al. by reported satiety assessed as a mean of a 244 
hunger-satiety score (HSSc)43,45. Martin et al. demonstrated reductions in evaluations of 245 
³SURVSHFWLYHFRQVXPSWLRQ´LQWKHLQWHUYHQWLRQJURXS compared to the control group, whereas 246 
eYDOXDWLRQVRI³KXQJHU´³GHVLUHWRHDW´DQG³IXOOQHVV´GLGQRWGLIIHUsignificantly between the 247 
groups, but these data were not shown in more detail41. Self-reported evaluations favoring 248 
motivation to eat were reported only as ³KXQJHU´ in the studies from the groups of Diepvens and 249 
Rigaud. A very clear effect on appetite was demonstrated in the studies by the groups of Martin, 250 
Rigaud and Sofer, where appetite decreased within the intervention groups after the intervention 251 
compared to baseline despite weight losses in these studies41,44,45. In contrast to the findings in these 252 
seven studies, the studies from the groups of Kamphuis and Rondanelli found no difference in 253 
weight development despite reduced appetite in the intervention groups compared to the control 254 
groups46,47. The first study consistently found a reduced motivation to eat in the intervention group 255 
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compared to the control group regardless of the scales used. This was also in line with findings in 256 
the second study; however, only approximately 1 mm higher ³fullness´ score in the intervention 257 
group compared to the control group was shown47.     258 
3.3 Overall effects of satiety enhancing and/or hunger reducing foods on body 259 
weight management  260 
Based on the mean difference in body weight change (kg) after exposure to satiety enhancing and/or 261 
hunger reducing foods compared to controls in the respective studies, the meta-analysis was 262 
conducted to provide an overview of the overall results (Figure 2). Overall, subjects exposed to 263 
satiety enhancing and/or hunger reducing foods coincidently reduced their body weight by 3.60 264 
(1.05; 6.15) kg (mean (95% CI)) more compared to controls. The studies were closely weighed in 265 
the random effects analysis; however, there was high uncertainty around the estimate (I2=98%). A 266 
sensitivity analysis excluding the two most deviating studies by Blundell et al. and Jakubowicz et 267 
al. resulted in a reduction but it remained high (I2=75%), with a lower body weight change relative 268 
to the control of -1.96 (-2.72; -1.20) kg. Comparable results were found in the fixed effects analysis 269 
including all the studies with a body weight change relative to control of -3.54 (-3.89; -3.20); 270 
I2=98%).    271 
3.4 Evaluations of risk of bias 272 
The risk of bias assessment of the studies included is summarized in Figure 2 and reported in more 273 
detail in Supplementary material Table 1. The majority of the studies were conducted as double-274 
blinded and those that were not, were due to inability to blind because of obvious differences 275 
between intervention and control foods. The majority of the studies reported complete outcome 276 
data; showed no sign of reporting bias; and experienced low drop-out rates. All studies were 277 
categorized as randomized, but the majority lacked detailed description of the randomization 278 
sequence along with lack of description of allocation concealment procedure. Additionally, none of 279 
the studies reported whether blinded data was assessed before breaking the allocation concealment. 280 
Several of the studies did not report whether a power calculation was performed in advance of the 281 
study. One study failed to reach 80% power, but this was not evaluated as a risk of bias as 282 
difference between intervention and control was detected anyway. One study assessed weight 283 
management using a cross-over design, which was evaluated to introduce a risk of bias.   284 
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4 Discussion 285 
Overall, the current literature supports a potential link between enhanced satiety/reduced hunger 286 
and beneficial effects on body weight management. Only two studies reported whether individual 287 
data on appetite (assessed as ad libitum energy intake in both studies) were associated with 288 
beneficial effects on body weight management and they reported relatively strong associations37,41. 289 
Along with the results from our meta-analysis, these results support a beneficial effect on body 290 
weight management of interventions that enhance satiety and/or reduce hunger. In the context of 291 
overweight and obesity, although rather moderate, the overall effect size on body weight change 292 
may be clinically relevant, especially considering weight loss maintenance. This was found 293 
regardless of whether the analysis was based on acute or sustained effects on appetite and whether 294 
appetite was assessed as energy intake or self-reported appetite evaluations. Theoretically, an 295 
alternative interpretation of the results could be that reduced body weight leads to reduced energy 296 
needs, which ultimately causes the reduced appetite. However, as several studies have shown that 297 
the motivation to eat increases after diet-induced weight loss15±17, this interpretation does not seem 298 
biologically relevant. 299 
4.1 Level of evidence from each of the studies 300 
The study from the group of Blundell assessed weight management using a cross-over design, 301 
introducing a risk of bias. The order of drug treatment (intervention/placebo) was taken into account 302 
in the analyses of the effects on weight. When placebo was given during the second period, the 303 
body weight slightly increased. This was likely due to a rebound effect after weight loss during 304 
administration of the active treatment. Nevertheless, a very clear sustained enhanced satiety/reduced 305 
hunger was shown in the intervention group (Table 2)40. In the studies by the groups of Jakubowicz 306 
and Sofer, the interventions consisted of different breakfasts in the intervention and the control 307 
group as a part of an isocaloric diet and isocaloric diets with different meal patterns, respectively. 308 
Appetite was assessed after exposure to the different breakfasts and before each meal for a 24 hour 309 
period, respectively. Thereby the differences in weight losses can be explained by the reduced 310 
appetite rather than differences in the entire diets. Dennis et al. tested acute effect on appetite using 311 
a cross-over design at baseline with a following parallel intervention period. Assessing the acute 312 
effect on appetite in a cross-over design in all the subjects increased the validity of this study. Body 313 
weight was then assessed in each group after the following intervention period with repeated 314 
exposure to the allocated foods36. The inconsistent results on self-reported appetite evaluations 315 
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reported in the study by Martin et al. introduce a risk of bias and consequently these results do not 316 
provide as strong evidence supporting that satiety enhancing and/or hunger reducing interventions 317 
are linked with beneficial effects on body weight. It is, furthermore, not reported whether the 318 
analyses of the self-reported appetite evaluations were adjusted for multiple testing in this study. 319 
However, a potential adjustment is unlikely to affect the effect seen on the evaluation of 320 
³SURVSHFWLYHFRQVXPSWLRQ´DVWKHS-value is relatively low (P=0.004). In the studies from the 321 
groups of Diepvens and Riguad, it is unknown whether it was predefined to assess hunger only, or 322 
whether additional self-reported appetite evaluations were assessed but not reported based on the 323 
effects they found.  324 
With the findings of increased motivation to eat after diet-induced weight loss15±17, it can be argued 325 
that a rather strong sustained effect on appetite is shown when appetite remains decreased despite a 326 
larger weight loss compared to the control groups41,44,45. Hence, unchanged appetite after diet-327 
induced weight loss should not necessarily be interpreted as a lack of sustained effect on appetite. 328 
This was found by Kudiganti et al. who reported maintained level of appetite in the intervention 329 
group despite greater weight loss compared to the control group while the control group showed an 330 
increased appetite after the weight loss, as could be expected after diet-induced weight loss (Table 331 
2)43. In the study by Rondanelli et al., the effect on appetite may have been too weak to affect body 332 
weight, possibly explaining why similar weight losses were found in both groups. However, 333 
Kamphuis et al. demonstrated differences in appetite of magnitudes comparable to those reported in 334 
the studies from the groups of Blundell, Diepvens, Jakubowicz, Kudiganti, Martin, Rigaud, and 335 
Sofer, but Kamphuis did not find this effect to be linked to improved body weight management39±46. 336 
It should be noted that appetite was also assessed based on energy intake in this study and no 337 
difference was found between the intervention and the control group in this parameter (Table 2)46. 338 
This may indicate that the reduced feelings of appetite shown after repeated exposures to this 339 
intervention may not have been sufficient to translate into differences in eating behavior and 340 
therefore no differences in body weight should be expected. However, in the studies by Blundell et 341 
al. and Martin et al., the reduced motivation to eat translated into reduced energy intake resulting in 342 
greater weight loss in the intervention groups compared to the control groups40,41. 343 
4.2 Acute vs. sustained effects on appetite 344 
The four studies assessing acute effects on appetite we identified, all supported the link between 345 
enhanced satiety/reduced hunger and improved body weight management. This suggests that it may 346 
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be sufficient to show an effect on appetite after a single exposure to a food. However, this is likely 347 
dependent on the specific mechanisms involved in altering the appetite after consumption. Some 348 
foods may have satiety enhancing and/or hunger reducing capacities when provided once, but the 349 
effect may be attenuated if the body is able to adapt to the manipulation. In order to affect body 350 
weight management, we assume that the effect of the food has to be sustained; thus, leading to 351 
decreased accumulated energy intake. Sustained reduction in appetite after repeated exposures of 352 
satiety enhancing and/or hunger reducing foods resulted in superior body weight management in 353 
seven out of nine studies identified. A sustained effect is obviously required in order for the food to 354 
have an effect on energy balance and hence be able to affect body weight management. 355 
Nevertheless, the sustained satiety enhancing effect may not necessarily be detectable after a long-356 
term intervention with repeated exposures using a traditional study design for a controlled study. As 357 
previously discussed, the normal response to weight loss includes an increase in the motivation to 358 
eat15,17. A progressively attenuated net effect on appetite should therefore be expected following an 359 
intervention that in itself results in decreased motivation to eat, which then leads to weight loss. To 360 
demonstrate the true sustained effect on appetite after weight loss, the proper study design should 361 
therefore include a weight-matched control group for comparison; demonstrating whether an effect 362 
on appetite is maintained after repeated exposures that lead to weight loss. The second best 363 
alternative could be to minimize the duration of repeated exposures so the reduction in body weight 364 
is still very small; thus, at least reducing this problem. There is no consensus regarding which 365 
duration of repeated exposures of a specific food is needed to demonstrate that an effect on appetite 366 
can be considered sufficiently sustained to have a beneficial effect on body weight management. 367 
Evaluations of whether demonstrated acute effects on appetite translate into sustained effects were 368 
recently reviewed by Halford et al.48. Their results suggest that in most cases where a robust acute 369 
effect on appetite was observed, the effect was likely to be sustained, particularly when assessing 370 
energy intake 48. These authors arrived at this conclusion despite the fact that potential 371 
counteracting effects of weight loss were not taken into account in this review. Therefore, the 372 
results of our review (which has focused on effects of foods on body weight) should be considered 373 
alongside the Halford et al. review. Taken together we feel that these two review papers provide an 374 
up to date comprehensive objective assessment of the science in this area.  375 
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4.3 Assessments of appetite from ad libitum energy intake vs. self-reported appetite 376 
evaluations 377 
From the meta-analysis and the studies that use both methods, we noted that results are quite 378 
consistent regardless if appetite is assessments as energy intake from an ad libitum meal or self-379 
reported appetite evaluations (Figure 2)37,40,41. However, the evidence supporting a link between 380 
enhanced satiety/reduced hunger and improved body weight management seems to be more robust 381 
when appetite is assessed as energy intake compared to self-reported appetite evaluations (Figure 382 
2). Self-reported appetite evaluations are probably affected by personal psychological matters to a 383 
greater extent than energy intake, thereby introducing more individual and day to day variation34. 384 
Additionally, self-reported appetite evaluations may be more prone to self-reporting bias than 385 
energy intake32. However, despite the fact that energy intake reflects behavior, the measure may 386 
also be affected by self-reporting and especially social desirability bias, as the subject may be aware 387 
that the investigator monitors how much food is consumed49. The laboratory settings are needed in 388 
order to standardize the appetite measurements, but the standardization may result in stylized 389 
behavior that may not be truly typical of thHVXEMHFW¶VXVXDOEHKDYLRU50.  390 
Gastrointestinal hormones believed to be involved in appetite control are not evaluated in this 391 
review. However, it is well documented that gastric bypass surgery promotes weight loss and 392 
improve the following body weight maintenance51 and that it is largely mediated by profound post-393 
prandial changes in gastrointestinal hormone secretion associated with enhanced satiety/reduced 394 
hunger52,53. Biological markers of appetite were assessed in five of the included studies37±39,42,43, but 395 
differences between the intervention and the control groups were only reported in three of these37±396 
39
. After a single exposure to the foods, the orexigenic hormone ghrelin was found to be lower37,39 397 
and the anorexigenic hormones GLP-1 and PYY were found to be higher in the intervention groups 398 
compared to the control groups37,38 in line with previous findings on associations between a number 399 
of gastrointestinal hormones and appetite54,55. From these studies, the differences in appetite 400 
detected by self-reported assessments are consistent with those reflected in objective measures, thus 401 
increasing the validity of the findings. As changes in eating behavior resulting in decreased energy 402 
intake are needed for the satiety enhancing and/or hunger reducing foods to improve body weight 403 
management, the subjective measures are necessary for investigating the aim of this review. The 404 
objective measures may provide a plausible mechanism validating the subjective assessments, but 405 
they do not necessarily reflect behavior.      406 
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4.4 Limitations of the review  407 
Publication bias (the tendency to publish positive rather than negative findings)56 cannot be ruled 408 
out and may have influenced the positive conclusions regarding a link between consumption of 409 
foods with satiety enhanced and/or hunger reducing properties and body weight management in the 410 
context of overweight and obesity.   411 
Finally, apart from two studies, the analyses in this review are based on assessments done on group 412 
levels. Rather more studies assessing relationship between individual data on appetite and effects on 413 
body weight management are required.    414 
5 Conclusion 415 
The evidence from the available literature supports the supposition that intake of foods that leads to 416 
post-ingestive enhancement of satiety/reduced hunger FRPSDUHGWR³UHJXODUIRRGV´may be linked to 417 
improved body weight management in the context of overweight and obesity. Based on the 418 
available literature, it may therefore be appropriate to hypothesize that appetite continues to be a 419 
promising target for novel food concepts, supplements and medical devices. Nevertheless, the 420 
number of studies is currently limited and with methodological issues that limit demonstrations of a 421 
causal link. This outcome highlights the need for studies specifically designed to demonstrate a 422 
causal link between enhanced satiety/reduced hunger of foods designed to be used for body weight 423 
management. This strategy may H[SDQGWKH³WRROER[´QHHGHGWRKHOSSHRSOHPDQDJHERG\ZHLJKW424 
in order to maintain health and wellbeing throughout life.   425 
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Table 1 Acute effects of appetite assessed after a single exposure on body weight management. 562 
M=Male; F=Female; SEM=Standard error of mean; I=Intervention; C=Control; CI=Confidence interval; DB=Double-563 
blinded; SB=Single-blinded; NB=Non-blinded; P=Parallel; RCT=Randomized controlled trial; NR=not reported; 564 
AUC=Area under the curve; Ĺ ,QFUHDVHKLJKHU; Ļ=Decrease/lower; ļ=unchanged/no difference; (?)=Significance 565 
difference is unknown. 566 
*R=Rating of the study. The rating represents whether the study supports that satiety enhancing and/or hunger reducing 567 
interventions are linked with beneficial effects on body weight management (+) or not (-). 568 
The grey areas indicate that the parameters were not assessed.  569 
 570 
Table 2 Sustained effects of appetite assessed after repeated exposures on body weight management. 571 
M=Male; F=Female; SEM=Standard error of mean; I=Intervention; C=Control; CI=Confidence interval; DB=Double-572 
blinded; SB=Single-blinded; NB=Non-blinded; CO=Cross-over; P=Parallel; RCT=Randomized controlled trial; 573 
NR=not reported; VAS=Visual analogue scale; AUC=Area under the curve; HSSc=Hunger-satiety score; 574 
Ĺ ,QFUHDVHKLJKHUĻ=Decrease/lower; ļ=unchanged/no difference; (?)=Significance of difference is unknown. 575 
*R=Rating of the study. The rating represents whether the study supports that satiety enhancing and/or hunger reducing 576 
interventions are linked with beneficial effects on body weight management (+) or not (-). 577 
The grey areas indicate that the parameters were not assessed.  578 
 579 
Figure 1 PRISMA flow chart explaining the systematic literature search in PubMed identifying studies 580 
potentially eligible for inclusion and available on PubMed up to February 22, 2019. 581 
After screening of MeSH term index list as well as testing numerous different combinations of search terms in order to 582 
conduct a search providing the most hits, the following search terms were selected as the final search syntax: 583 
µ³DSSHWLWH´OR ³VDWLHW\´OR ³VDWLDWLRQ´25³VDWLHW\UHVSRQVH´OR ³KXQJHU´OR ³KXQJHUUHVSRQVH´OR ³KXQJU\´) 584 
AND ´ERG\ZHLJKWFKDQJHV´OR ³ERG\ZHLJKWPDLQWHQDQFH´OR ³ZHLJKWORVV´OR ³ZHLJKWJDLQ´¶ 585 
The reference lists of these 12 eligible papers were subsequently screened and additional 12 potentially relevant papers 586 
were selected for full-text screening. However, these were subsequently excluded for further considerations. 587 
 588 
Figure 2 Meta-analysis of mean difference in body weight change with 95% CI (kg) between exposure to satiety 589 
enhancing and/or hunger reducing foods and matching control foods in each of the studies.  590 
CI=Confidence interval 591 
Assessments of appetite are classified according to whether appetite was assessed as energy intake from an ad libitum 592 
meal and self-reported appetite evaluations, energy intake from an ad libitum meal alone or self-reported appetite 593 
evaluations alone. The grey marks around the mean from each study indicates the weight of the evidence from each 594 
study assessed in a random effects analysis; the blue diamonds summarizes the total mean differences according to the 595 
assessments of appetite and finally for the overall result with width of the diamonds indicating the 95% CI.  596 
Only the studies from the groups of Chambers and Rondanelli directly reported the mean difference in body weight 597 
change (95% CI) (kg). For the remaining studies, the effect sizes were calculated based on reported changes within each 598 
group. No standard deviation, standard error of mean (SEM) or 95% CI for the changes in body weight within each 599 
group was reported in the studies from the groups of Blundell and Wang. The corresponding authors were asked to 600 
provide these data, but data could not be made available for this review. The 95% CI was therefore imputed based on 601 
the average SEM from the other studies36. 602 
Risk of bias was assessed based on the following categories: A: Random sequence generation (selection bias); B: 603 
Allocation concealment (selection bias); C: Blinding of participants and personnel (performance bias); D: Blinding of 604 
outcome assessment (detection bias); E: Incomplete outcome data (attrition bias); F: Selective reporting (evaluated for 605 
self-reported appetite evaluations) (reporting bias); G: Power calculation; H: Drop outs; I: Other bias. Risk of bias was 606 
UDWHGDV³/RZ´RU³+LJK´DFFRUGLQJWRSUHGHILQHGVSHFLILFDtions (see Supplementary material Table 1) or ³8QFOHDU´LI607 
no information on a potential bias was reported. 608 
